{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T07:40:10Z","timestamp":1745739610300,"version":"3.40.4"},"posted":{"date-parts":[[2025,1,8]]},"group-title":"In Review","reference-count":1,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,1,4]]},"abstract":"<title>Abstract<\/title>\n        <p>We examined the risk of subsequent malignant neoplasms (SMNs) in 1720 patients with hematologic cancers given allogeneic hematopoietic grafts from 03\/1998 to 08\/2023 after nonmyeloablative conditioning regimens. With a median follow-up of 12 years, the cumulative incidence of SMNs was 17% (95% CI, [15%, 19%]). Most SMNs (n\u2009=\u2009543) were non-melanoma skin cancers seen in 208 patients; unfortunately, information on these cancers was not available in the Surveillance, Epidemiology, and End Results (SEER) database for comparison with such tumors in the general population. However, developing non-melanoma skin cancers was statistically significantly associated with chronic GVHD and, thus, unlikely to be conditioning regimen related. Eighty-six patients (5%) developed 93 other SMNs. This number (93 SNMs) significantly exceeded the expected 73.4 cases in the comparison group (p\u2009=\u20090.03). This increase was driven exclusively by increases in uterine adenocarcinoma (n\u2009=\u20092), squamous lip cancer (n\u2009=\u20095), and squamous penile cancer (n\u2009=\u20092); the latter two cancers were, again, associated with chronic GVHD. Apart from these three tumor types, there were no observed increases in the risk of other tumors compared to those in the general population.<\/p>","DOI":"10.21203\/rs.3.rs-5760731\/v1","type":"posted-content","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:54:56Z","timestamp":1736366096000},"source":"Crossref","is-referenced-by-count":0,"title":["Subsequent Cancers following Non-myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-0244","authenticated-orcid":false,"given":"Phuong","family":"Vo","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Ng","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Gary","family":"Schoch","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-8054","authenticated-orcid":false,"given":"Jason","family":"Cooper","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Vupalanchi","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Flowers","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9767-9739","authenticated-orcid":false,"given":"Brenda","family":"Sandmaier","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-4099","authenticated-orcid":false,"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.4710350716","author":"McSweeney PA","year":"2024","unstructured":"as of Dec 11, 2024 1. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97(11): 3390\u20133400. doi: 10.1182\/blood.v97.11.3390 2. Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101(4): 1620\u20131629. 3. Surveillance, Epidemiology, and End Results Program (SEER). The website of the National Cancer Institute: https:\/\/seer.cancer.gov\/. 4. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF et al. SEER Cancer Statistics Review, 1975\u20132012. In. Bethesda, MD: National Cancer Institute, 2015. 5. Sahai H, Khurshid A. Statistics in Epidemiology: Methods, Techniques, and Applications, CRC-Press: Boca Raton, FL, 1996. 6. Sahai H, Khurshid A. Confidence Intervals for the Mean of a Poisson Distribution: A Review. Biometrical Journal 1993; 35(7): 857\u2013867. doi: https:\/\/doi.org\/10.1002\/bimj.4710350716 7. SEER*Stat Help System: Standardized Incidence Ratio and Confidence Levels. In. Bethesda, MD: National Cancer Institute. 8. Wickham H. ggplot2: Elegant Graphics for Data Analysis, Spriinger-Verlag: New York, 2016. https:\/\/ggplot2.tidyverse.org. 9. Vo P, Onstad L, Flowers ME, Storb R. Cancers after HLA-matched related bone marrow transplantation for aplastic anemia. Bone Marrow Transplant 2022; 57(1): 83\u201388. e-pub ahead of print 20211016; doi: 10.1038\/s41409-021-01498-1 10. Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005; 105(10): 3802\u20133811. e-pub ahead of print 20050201; doi: 10.1182\/blood-2004-09-3411 11. Baker KS, Leisenring WM, Goodman PJ, Ermoian RP, Flowers ME, Schoch G et al. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation. Blood 2019; 133(26): 2790\u20132799. e-pub ahead of print 20190416; doi: 10.1182\/blood.2018874115 12. Rangwala S, Tsai KY. Roles of the immune system in skin cancer. Br J Dermatol 2011; 165(5): 953\u2013965. doi: 10.1111\/j.1365-2133.2011.10507.x 13. Rambhia PH, Conic RZ, Atanaskova-Mesinkovska N, Piliang M, Bergfeld WF. Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: A meta-analysis. J Am Acad Dermatol 2018; 79(2): 378\u2013380 e373. e-pub ahead of print 20180112; doi: 10.1016\/j.jaad.2018.01.012 14. Schwartz JL, Kopecky KJ, Mathes RW, Leisenring WM, Friedman DL, Deeg HJ. Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat Res 2009; 171(2): 155\u2013163. doi: 10.1667\/RR1469.1 15. Cavalier M, Shmalo JA, Yu M, Billings SD, Abonour R, Nelson RP, Jr. Skin cancer after nonmyeloablative hematopoietic cell transplantation. Bone Marrow Transplant 2006; 37(12): 1103\u20131108. doi: 10.1038\/sj.bmt.1705362 16. Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S et al. Continuing increased risk of oral\/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 2014; 25(2): 435\u2013441. e-pub ahead of print 20140107; doi: 10.1093\/annonc\/mdt558 17. DePry JL, Vyas R, Lazarus HM, Caimi PF, Gerstenblith MR, Bordeaux JS. Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: A systematic review. JAMA Dermatol 2015; 151(7): 775\u2013782. doi: 10.1001\/jamadermatol.2015.121 18. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 Suppl 1: S105-143. doi: 10.1016\/S0020-7292(06)60031-3 19. Chi DS, Berchuck A, Dizon DS, Yashar CM. Principles and Practice of Gynecologic Oncology, 7th edn Lippincott Williams & Wilkins: Philadelphia, 2017."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5760731\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5760731\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T07:07:14Z","timestamp":1745737634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5760731\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":1,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5760731\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41409-025-02606-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,1,8]]},"subtype":"preprint"}}